tirzepatide in ozempic Tops Semaglutide for Weight Loss Head-to-Head Trial, Eli Lilly Says Same needle, different power. Ozempic

Age at menopause was collected when reported in the EMR

SURPASS-5 (Add-on to Insulin Glargine) To assess its utility in patients with advanced T2D, the SURPASS-5 trial evaluated Tirzepatide as an add-on therapy to titrated insulin glargine, with or without metformin, in 475 patients

Starting at higher body weight If you are beginning your GLP-1 protocol at a higher body weight, you likely have ample subcutaneous tissue at all three injection sites

PT-141 is not approved by the MHRA for any therapeutic indication in the UK

Many PlexusDx patients find that eating 5-6 ounces of protein at lunch and dinner, paired with non-starchy vegetables and whole grains, creates sustainable satiety without feeling restrictive

Nausea (particularly with higher doses)